Ronald van der Geest, Senior Consultant Clinical Development at 3D-PharmXchange
Ronald is one of the founders of 3D-PharmXchange. Next to his role as general partner, he holds roles as CDO at Treeway since 2013 and similar roles for a number of biotech companies. He is inventor on a substantial number of patents and an advisor for various strategic development programs in the life sciences and involved in the establishment of a number of early start-up companies. He led the development of Glybera™ for uniQure, the 1st approved genetherapy product and holds strategic knowledge in the areas of translational development, orphan drugs, individualized medicines and biomarker-based development. He currently holds the position of Early Development Project Lead for a top-tier European biotech company. Prior to co-founding 3D-PharmXchange Ronald was COO/CDO at Kinesis Pharma. Prior to that he worked for Tibotec/J&J as Compound Development Leader for Prezista®.
Ronald is a PhD-level clinical pharmacologist and drug delivery expert by training (Leiden University and UC San Francisco) and started his career in this area at Johnson & Johnson, Belgium.